清肺消炎饮治疗急性上呼吸道感染风温肺热证临床研究  

Clinical Research of Qingfei Xiaoyan Decoction for the Treatment of Acute Upper Respiratory Tract Infection Wind Warm and Lung Heat Syndrome

作　　者：王哲[1] 陈海铭[1] 王宇[1] 张雪梅[1] 

机构地区：[1]辽宁中医药大学附属医院,辽宁沈阳110032

出　　处：《辽宁中医药大学学报》2017年第6期80-82,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：沈阳市科技计划项目(F14-231-1-14)

摘　　要：目的:评价清肺消炎饮治疗急性上呼吸道感染风温肺热证的临床疗效。方法:将200例急性上呼吸道感染患者随机分为2组,试验组予以清肺消炎饮50 mL日3次口服。对照组予以对乙酰氨基酚、复方甘草片、必嗽平对症治疗。观察患者即刻退热时间、临床疗效。结果:试验组、对照组给药后体温均较给药前下降,差异有统计学意义(P<0.01),试验组与对照组各时间点体温下降值比较差异均无统计学意义(P>0.05);两组治疗疾病总体疗效比较,痊愈率、愈显率比较,试验组优于对照组(P<0.01)。结论:对急性上呼吸道感染发热患者有明显降低体温、减少发热时间和改善临床症状的作用。Objective： To observe the therapeutic effect of Qingfei Xiaoyan Decoction wind warm and lung heat syndrome in treatment of acute upper respiratory tract infection. Methods ： 200 cases of acute upper respiratory tract infection were randomly divided into 2 groups, the experimental group was given Qingfei Xiaoyan Decoction 50 mL three times a day. The control group was given paracetamol, Compound Liquorice Tablets, bisolvon symptomatic treatment. To observe the immediately antipyretic time and clinical curative effect. Results ： Experimental group and control group after administration of temperature were administered before decreased, the difference was statistically significant （P〈0.01）, the experimental group and the control group of immediate hypothermia values showed no significant difference （ P〉0.05 ）; the two groups overall efficacy comparison, treatment of disease cure rate and effective rate comparison test group than the control group （ P〈0.01 ）. Conclusion ： Qingfei Xiaoyan Decoction on acute upper respiratory tract infection has significantly lower body temperature, shorten the duration of fever, improve the clinical symptoms.

关 键 词：清肺消炎饮 呼吸道感染 风温肺热证 

分 类 号：R373.1[医药卫生—病原生物学]